Abstract Since the introduction of insulin almost a century ago, more than 80 peptide drugs have reached the market for a wide range of diseases, including diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection and chronic pain
Published research uses varying doses depending on the model and endpoint
That single-molecule design is what separates it from stacking three drugs: the pharmacokinetics are unified, and the once-weekly half-life comes from a fatty-acid modification similar to the one used on semaglutide and tirzepatide
For some women with PCOS, combining medication with lifestyle changes can be meaningful, often helping support modest, clinically significant weight loss that improves symptoms and key health measures like blood sugar, cholesterol, and waist size over time